Related Experiment Video

Updated: Jun 11, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

A link between hypertension and atrial fibrillation: methods of treatment and prevention

Tonje A Aksnes1, Sverre E Kjeldsen

  • 1Department of Cardiology, Oslo University Hospital, Ulleval, Oslo, Norway. TonjeAmb.Aksnes@ulleval.no

Current Vascular Pharmacology
|July 15, 2010
PubMed

Insights

Aggressively treating hypertension, particularly with renin-angiotensin system blockers, can prevent atrial fibrillation and reduce cardiovascular risks. Optimal antihypertensive treatment is key for preventing atrial fibrillation, lowering mortality and healthcare costs.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Arrhythmia Studies

Background:

  • Atrial fibrillation is a prevalent cardiac arrhythmia, significantly increasing cardiovascular disease risk.
  • Hypertension and atrial fibrillation frequently coexist, contributing to substantial morbidity and mortality.
  • Effective hypertension management is crucial for cardiovascular health.

Purpose of the Study:

  • To investigate the impact of aggressive hypertension treatment on atrial fibrillation development.
  • To explore the role of renin-angiotensin system blockers in preventing atrial fibrillation.
  • To highlight the importance of optimal antihypertensive strategies for reducing cardiovascular complications and healthcare costs.

Main Methods:

  • Review of existing literature on hypertension and atrial fibrillation.
  • Analysis of the effects of antihypertensive therapies, including renin-angiotensin system blockers.
  • Epidemiological assessment of morbidity and mortality associated with coexisting hypertension and atrial fibrillation.

Main Results:

  • Aggressive hypertension treatment, especially with renin-angiotensin system blockers, may delay or prevent atrial fibrillation onset.
  • Optimal antihypertensive management can decrease the incidence of thromboembolic events.
  • Early detection and management of hypertension are vital for preventing atrial fibrillation.

Conclusions:

  • Optimal antihypertensive treatment is essential for preventing atrial fibrillation in hypertensive patients.
  • Targeted treatment of hypertension can significantly reduce cardiovascular morbidity, mortality, and associated healthcare expenditures.
  • Increased awareness of atrial fibrillation risks in hypertensive individuals is critical for proactive management.

More Related Videos

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Transesophageal Atrial Burst Pacing for Atrial Fibrillation Induction in Rats05:12

Transesophageal Atrial Burst Pacing for Atrial Fibrillation Induction in Rats

Published on: February 14, 2022

Related Concept Videos

Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...